Effectiveness of Y-90-antitenascin MAbs loco-regional radioimmunotherapy of malignant gliomas:: An ongoing phase II trial.

被引：0
|
作者：
Riva, P
Franceschi, G
Frattarelli, M
Riva, N
Casi, M
Guiducci, G
Giuliani, G
Santimaria, M
Amato, M
Mäke, H
机构：
[1] M Bufalini Hosp, Dept Nucl Med, Cesena, Italy
[2] M Bufalini Hosp, Dept Neurosurg, Cesena, Italy
[3] M Bufalini Hosp, Oncol Romagnolo 1, Cesena, Italy
[4] Kantonsspital Basel, Inst Nucl Med, Basel, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1999年 / 26卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OS34
引用
收藏
页码：969 / 969
页数：1
相关论文
共 21 条
  • [1] Loco-regional radioimmunotherapy with Y-90 labelled monoclonal antibodies in the treatment of high grade malignant glioma: A phase I and phase II trial
    Riva, P
    Franceschi, G
    Frattarelli, M
    Casi, M
    Gentile, R
    Cremonini, AM
    Guiducci, G
    Riva, N
    ANNALS OF ONCOLOGY, 1998, 9 : 74 - 74
  • [2] Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y:: A phase I study
    Riva, P
    Franceschi, G
    Frattarelli, M
    Lazzari, S
    Riva, N
    Giuliani, G
    Casi, M
    Sarti, G
    Guiducci, G
    Giorgetti, G
    Gentile, R
    Santimaria, M
    Jermann, E
    Maeke, HR
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3275S - 3280S
  • [3] Loco-regional radioimmunotherapy of high grade malignant gliomas using the humanized monoclonal antibody, h-R3, labeled with 188-Re.
    Casaco, A
    López, G
    Fernandez, R
    Diaz, L
    Perera, A
    Batista, J
    Leyva, R
    Peña, Y
    Rodriguez, JA
    Garcia, I
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 170S - 170S
  • [4] Loco-regional radioimmunotherapy (RIT) of high grade malignant gliomas using the humanized monoclonal antibody, h-R3, labeled with 188-Re.
    Casacó, A.
    López, L.
    Garcia, I
    Rodríguez, J. A.
    Figueredo, J.
    Fernández, R.
    Torres, L.
    Pereira, A.
    Batista, J.
    Leiva, R.
    Peña, Y.
    Amador, Z.
    González, A.
    Estupinan, B.
    Coca, M.
    Hernández, A.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 429 - 429
  • [5] Radioimmunotherapy of colorectal cancer patients with small volume disease:: Results of an ongoing phase-I/II trial.
    Behr, TM
    Liersch, T
    Gratz, S
    Schmidt, F
    Canelo, R
    Lorf, T
    Post, S
    Wörmann, B
    Hiddemann, W
    Becker, H
    Ringe, B
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 70P - 70P
  • [6] Pattern of Loco-Regional Failure after Definitive Chemo Radiotherapy for NSCLC. Results from NARLAL, a Phase II Randomized Trial
    Schytte, Tine
    Nielsen, Tine B.
    Knap, Marianne
    Khalil, Azza
    Nyhus, Christa
    Mcculloch, Tine
    Holm, Bente
    Brink, Carsten
    Hansen, Olfred
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S287 - S287
  • [7] Direct infusion of Y-90 labelled MABs into the surgical postoperative cavity of malignant glioma: A phase II study.
    Riva, P
    Franceschi, G
    Frattarelli, M
    Casi, M
    Adamo, R
    Polito, C
    Giuliani, G
    Guiducci, G
    Santimaria, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (01): : S84 - S84
  • [8] Carbon ion reirradiaton for patients with malignant gliomas: Toxicity and first results of the prospective dose-escalation phase I/II CINDERELLA trial.
    Combs, Stephanie E.
    Bernhardt, Denise
    Adeberg, Sebastian
    Herfarth, Klaus K.
    Unterberg, Andreas
    Wick, Wolfgang
    Debus, Juergen
    Rieken, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] IDEC-Y2B8 (90)yttrium anti-CD20 radioimmunotherapy of relapsed non-Hodgkin's lymphoma (NHL): Interim results of a Phase I/II trial.
    Witzig, T
    Wiseman, C
    White, CA
    Solinger, A
    Gordon, L
    Raubitschek, A
    Emmanoulides, C
    Royston, I
    Parker, E
    Chinn, P
    GrilloLopez, A
    BLOOD, 1997, 90 (10) : 2606 - 2606
  • [10] Phase II trial of murine 131I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas
    Reardon, DA
    Akabani, G
    Coleman, RE
    Friedman, AH
    Friedman, HS
    Herndon, JE
    Cokgor, I
    McLendon, RE
    Pegram, CN
    Provenzale, JM
    Quinn, JA
    Rich, JN
    Regalado, LV
    Sampson, JH
    Shafman, TD
    Wikstrand, CJ
    Wong, TZ
    Zhao, XG
    Zalutsky, MR
    Bigner, DD
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1389 - 1397
123